Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Revenue

Arcutis Biotherapeutics had revenue of $105.40M in the quarter ending March 31, 2026, with 60.07% growth. This brings the company's revenue in the last twelve months to $415.62M, up 95.29% year-over-year. In the year 2025, Arcutis Biotherapeutics had annual revenue of $376.07M with 91.34% growth.

• Revenue (ttm): $415.62M
• Revenue Growth: +95.29%
• P/S Ratio: 7.34
• Revenue / Employee: $1,174,079
• Employees: 354
• Market Cap: 3.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	376.07M	179.53M	91.34%
Dec 31, 2024	196.54M	136.94M	229.74%
Dec 31, 2023	59.61M	55.92M	1,517.09%
Dec 31, 2022	3.69M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error